Literature DB >> 27432432

Prostate cancer survivors with a passive role preference in treatment decision-making are less satisfied with information received: Results from the PROFILES registry.

Maarten Cuypers1, Romy E D Lamers2, Marieke de Vries3, Olga Husson4, Paul J M Kil2, Lonneke V van de Poll-Franse5.   

Abstract

OBJECTIVE: To investigate decision-making role preferences and their association with the evaluation of information received in a sample of low-risk and intermediate-risk prostate cancer (Pca) survivors.
METHODS: Cross-sectional study involved 562 men diagnosed with low-risk or intermediate-risk Pca (median time since diagnosis, 48mo), measuring preferred decision-making role (Control Preference Scale) and the evaluation of information received (EORTC QLQ-INFO25). Analyses were performed using analysis of variance, chi-square tests, and multivariable linear regression models.
RESULTS: Men who preferred a passive role were older and less educated than other preference groups and more often selected a noninvasive treatment option (all with P<0.001). The passive role preference group reported having received less information, judged the received information as less helpful, and indicated lower overall satisfaction with information received (all with P<0.05). Role preference groups did not differ in their desire to receive more information.
CONCLUSION: Compared with nonpassive preference groups, the preference for a passive role in Pca treatment decision-making is associated with less satisfaction with the information received. PRACTICE IMPLICATIONS: Assessment of role preferences and tailored information provision could improve satisfaction with information received and perhaps may ultimately lead to improved patient participation in treatment decision-making.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Decision-making roles; Information provision; Patient participation; Preferences; Prostate cancer; Shared decision-making

Mesh:

Year:  2016        PMID: 27432432     DOI: 10.1016/j.urolonc.2016.06.015

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  6 in total

1.  The impact of caregiver's role preference on decisional conflicts and psychiatric distresses in decision making to help caregiver's disclosure of terminal disease status.

Authors:  Shin Hye Yoo; Young Ho Yun; Kyoung-Nam Kim; Jung Lim Lee; Jeanno Park; Youn Seon Choi; Yeun Keun Lim; Samyong Kim; Hyun Sik Jeong; Jung Hun Kang; Ho-Suk Oh; Ji Chan Park; Si-Young Kim; Hong Suk Song; Keun Seok Lee; Dae Seog Heo; Young Seon Hong
Journal:  Qual Life Res       Date:  2018-02-24       Impact factor: 4.147

2.  Ethnographic investigation of patient-provider communication among African American men newly diagnosed with prostate cancer: a study protocol.

Authors:  Nynikka R Palmer; Janet K Shim; Celia P Kaplan; Dean Schillinger; Sarah D Blaschko; Benjamin N Breyer; Rena J Pasick
Journal:  BMJ Open       Date:  2020-08-05       Impact factor: 2.692

Review 3.  Empowering patients in decision-making in radiation oncology - can we do better?

Authors:  Michelle Leech; Matthew S Katz; Joanna Kazmierska; Julie McCrossin; Sandra Turner
Journal:  Mol Oncol       Date:  2020-04-13       Impact factor: 6.603

4.  Mind the gap: Physicians' assessment of patients' importance weights in localized prostate cancer.

Authors:  Katya Tentori; Stefania Pighin; Claudio Divan; Vincenzo Crupi
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

5.  Health-related quality Of Life In patients with advanced Soft TIssue sarcomas treated with Chemotherapy (The HOLISTIC study): protocol for an international observational cohort study.

Authors:  Eugenie Younger; Robin L Jones; Ingrid M E Desar; Clare Peckitt; Winette T A van der Graaf; Olga Husson
Journal:  BMJ Open       Date:  2020-06-01       Impact factor: 2.692

Review 6.  Shared decision making in surgery: a scoping review of patient and surgeon preferences.

Authors:  Laura A Shinkunas; Caleb J Klipowicz; Erica M Carlisle
Journal:  BMC Med Inform Decis Mak       Date:  2020-08-12       Impact factor: 2.796

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.